Non-operative management after chemoradiotherapy plus consolidation or sandwich (induction with bevacizumab and consolidation) chemotherapy in patients with locally advanced rectal cancer: a multicentre, randomised phase II trial (NOMINATE trial)Takashi Akiyoshi, Tsuyoshi Konishi, Koji Okabayashi et al.|BMJ Open|2022Cited by 14
Adding Induction Chemotherapy Before Chemoradiotherapy with Total Mesorectal Excision and Selective Lateral Lymph Node Dissection for Patients with Poor-Risk, Locally Advanced, Mid-to-Low Rectal Cancer May Improve Oncologic Outcomes: A Propensity Score-Matched AnalysisTomohiro Yamaguchi, Tsuyoshi Konishi, Takashi Akiyoshi et al.|Annals of Surgical Oncology|2023Cited by 11
Features of Lateral Pelvic Lymph Nodes Associated With Pathological Involvement After Total Neoadjuvant Therapy in Patients Undergoing Lateral Pelvic Lymph Node DissectionTatsuki Noguchi, Yosuke Fukunaga, Takashi Akiyoshi et al.|Diseases of the Colon & Rectum|2024Cited by 5
2175 Genetic variants of UGT1A1 and 1A9 could be associated with Regorafenib induced toxicity in Japanese patients with metastatic colorectal cancerTakeru Wakatsuki, Tomohiro Yamaguchi, Mitsukuni Suenaga et al.|European Journal of Cancer|2015Cited by 3
Safety and tolerability of different total neoadjuvant therapy strategies in patients with locally advanced rectal cancer.Shohei Udagawa, Eiji Shinozaki, Hiroki Osumi et al.|Journal of Clinical Oncology|2025Cited by 1